-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903.P1.37 903. Health Services and Quality Improvement – Myeloid Malignancies: Poster I

Symposia: Health Services and Quality Improvement –Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Maria Queralt Salas1*, Maria Teresa Solano1*, Mónica Baile González2*, Marina Acera Gómez2*, Maria Laura Fox, MD3*, Maria del Mar Pérez Artigas3*, Ana Santamaria4*, María del Carmen Quintela González4*, Andres Sanchez Salinas5*, Joaquina Salmeron Camacho5*, Veronica Illana Álvaro6*, Zahra Abdallahi Lefdil6*, Javier Cornago7*, Laura Pardo7*, Sara Fernandez-Luis8*, Leddy Patricia Vega Suárez8*, Sara Villar9*, Patricia Beorlegui Murillo10*, Albert Esquirol11*, Isabel Izquierdo12*, Sonia González Rodriguez13*, Alberto Mussetti, MD13*, Esperanza Lavilla14*, Javier López Marin15*, Leyre Bento16*, Angel Cedillo17* and Anna Maria Sureda Balari, MD, PhD18

1Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
2Servicio de Hematología y Hemoterapia del Complejo Asistencial Universitario de Salamanca -IBSAL, Salamanca, Spain
3Vall d'Hebron University Hospital, Barcelona, Spain
4Hospital Álvaro Cunqueiro, Vigo, Spain
5Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
6Hospital Universitario de la Princesa, Madrid, Spain
7Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
8Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
9Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain
10Hematology and Cell Therapy Department, Clinica Universidad de Navarra, Navarra, Spain
11Hematology Departmen, Hospital de Sant Pau, Barcelona, Spain
12Hospital Universitario Miguel Servet, Zaragoza, Spain
13Institut Catala d’Oncologia-Hospitalet, Clinical Hematology Department, Barcelona, Spain
14Hospital Universitario Lucus Augusti, Lugo, Spain
15Hospital General de Alicante, Alicante, Spain
16Hematology Department, Hospital Universitario Son Espases, IdISBa, Palma De Mallorca, Spain
17GETH Data Office, Madrid, ESP
18Hospital Duran i Reynals, Institut d’Investigacio Biomedica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain, Barcelona, Spain

Andrew Hantel, MD1, Jonathan M. Marron, MD, MPH1*, Kenneth Kehl, MD, MPH1*, Richard Sharp, PhD2*, Thomas P Walsh1*, Eliezer Van Allen, MD, PhD1* and Gregory A Abel, MD, MPH3

1Dana-Farber Cancer Institute, Boston, MA
2Mayo Clinic, Rochester, MN
3DFCI, Boston, MA

Scott F. Huntington, MD, MPH1, Hsien-Yen Chang, PhD2*, Alex Z. Fu2,3*, Christina Loefgren, MD, PhD4 and Xiaoxiao Lu5*

1Division of Hematology, Yale University, New Haven, CT
2Janssen Scientific Affairs, LLC, Titusville, NJ
3Georgetown University Medical Center, Washington, DC
4Janssen Global Services, LLC, Raritan, NJ
5Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA

Rachel Rodenbach, MD1, Thorunn Thordardottir, MD2, Markus Brauer, PhD3*, Aric C. Hall, MD4*, Earlise Ward, PhD5* and Toby Campbell, MD MSCI6*

1University of Rochester School of Medicine and Dentistry, Rochester, NY
2University of Wisconsin School of Medicine and Public Health, Madison, WI
3Department of Psychology, University of Wisconsin, Madison
4Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
5Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison
6University of Wisconsin School of Medicine and Public Health, Madison

Lauren Laufer, MS, BA1, Lemchukwu Amaeshi, MD2, Alex Sisto, MD3*, Kateryna Fedorov, MD4,5, Rosmi Mathew6*, David Levitz, MD5, Ioannis Mantzaris5, Noah Kornblum, MD5, Mendel Goldfinger, MD5*, Alejandro Sica, MD5*, Dennis L Cooper, MD5, Marina Y. Konopleva5,7, Bruce Rapkin6*, Amit Verma, MD8, Aditi Shastri, MD9 and Nishi Shah, MBBS, MPH5

1Albert Einstein College Of Medicine/Montefiore Medical Center, Bronx, NY
2Montefiore Medical Center, Bronx, NY
3Montefiore Medical Center and Albert Einstein College of Medicine, Bronx
4Oncology, Vanderbilt University Medical Center, Nashville, NY
5Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
6Montefiore Medical Center, Bronx
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
9Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY

Rahul Mishra, MBBS1, Xuefei Jia, MS2*, Debolina Pramanik, MD3*, Abhay Singh, MD, MPH3, Sindhusha Veeraballi, MD3*, Sophia Balderman, MD3*, John C Molina, MD, MEd3, Anjali S. Advani, MD3, Moaath K. Mustafa-Ali, MD, MPH3*, Hetty E. Carraway, MD, MBA3, Aaron T. Gerds, MD, MS3, Nargiz F Muganlinskaya, MD1* and Sudipto Mukherjee, MD, PhD, MPH4

1Department of Internal Medicine, Anne Arundel Medical Center, Annapolis, MD
2Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH
3Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
4Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Kah Poh (Melissa) Loh, MD1, Soroush Mortaz-Hedjri, MD, MS1*, Ying Wang, MS1*, Marissa Locastro, BS1*, Sally Norton, PhD, RN, FNAP, FPCN, FAAN1*, Jason H. Mendler, MD1, Jane L. Liesveld, MD2, Eric J Huselton, MD3*, Marielle Jensen-Battaglia, PT, DPT, GCS1*, Kathryn Buettner, MA1*, Jenae Davis, BA, MPH1*, Heidi Klepin, MD4 and Daniel R. Richardson, MD, MSc, MA5

1University of Rochester Medical Center, Rochester, NY
2James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
3James P Wilmot Cancer Center, Rochester, NY
4Wake Forest University School of Medicine, Winston Salem, NC
5University of North Carolina, Chapel Hill, NC

Jaime M. Preussler, MS1,2*, Anna M. DeSalvo, MS, CGC3*, Ben Tweeten, MSW, LICSW3*, Brenna O'Brien, RN, MPH3*, Katie Schoeppner, MSW, LICSW3* and Jennifer A. Sees Coles, MPH3*

1CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match,, Minneapolis, MN
2National Marrow Donor Program/Be The Match, Minneapolis, WI
3National Marrow Donor Program/Be The Match, Minneapolis, MN

Pei-An Lee, PhD1,2,3*, Clark Dumontier, MD3,4,5,6*, Wanting Yu, ME1,2*, Kristi T Ho, BA4*, Nicholas Groblewski, BA4*, JunHong Zhou1,2,3*, Thomas Travison, PhD1,2,3*, Marcia Testa, MPH, MPhil, PhD7*, Tammy Hshieh, MD, MPH3,4,5*, Dae Kim, MD, MPH, ScD1,2,3*, Jane A Driver, MD, MPH3,5,6*, On-Yee Lo, PhD1,2,3*, Brad Manor, PhD1,2,3* and Gregory A Abel, MD, MPH3,5,8

1Hinda and Arthur Marcus Institute for Aging Research, Boston, MA
2Hebrew SeniorLife, Boston, MA
3Harvard Medical School, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA
5Brigham and Women’s Hospital, Boston, MA
6Veterans Affairs Boston Healthcare System, Boston, MA
7Harvard T.H. Chan School of Public Health, Boston, MA
8DFCI, Boston, MA

Claire N Harrison1,2, Prithviraj Bose, MD3, Martin H. Ellis, MD4*, Vikas Gupta, MD5, Jean-Jacques Kiladjian, MD, PhD6, John Mascarenhas, MD7*, Vikram Mathews, MD8, Francesco Passamonti, MD9,10* and Steffen Koschmieder11,12,13

1Guy’s and St. Thomas’ NHS Foundation Trust, London, ENG, United Kingdom
2Shared first authorship, London, United Kingdom
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Hematology Institute and Blood Bank, Meir Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
5Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
6Hôpital Saint-Louis, Université de Paris, Paris, France
7Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
8Department of Haematology, Christian Medical College, Vellore, Ranipet, Tamil Nadu, India
9Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
10Università degli Studi di Milano, Milano, Italy
11Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany
12Shared first authorship, Aachen, Germany
13Department of Haematology, Oncology, Haemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany

Riyana Doshi, BS1*, Karla Martin Gonzalez, MPP2*, Alavi Hossain, MBBS MPH3*, Alexzandra T Gentsch, LSW2*, Angelica Vivero4*, Lindsay Wilde, MD5, Kristin L Rising, MD2* and Adam F. Binder, MD6

1Sidney Kimmel Medical College, Philadelphia, PA
2Center For Connected Care, Thomas Jefferson University, Philadelphia
3Sidney Kimmel Medical College, Philaldephia
4Thomas Jefferson University Hospital, Philadelphia
5Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
6Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA

Brooke Kania, DO1, David Awad, PharmD2*, Michael Kane, PharmD3*, Andrew M Evens, DO, MBA, MSc4 and Neil Palmisiano, MD, MS5

1Department of Medicine, Rutgers Robert Wood Johnson Medical School, Parsippany, NJ
2Department of Pharmacy, Robert Wood Johnson University Hospital, New Brunswick, NJ
3Department of Pharmacy, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
4Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
5Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Tamir Sirkis1*, Christopher Wragg2*, Elisabeth Nacheva, MD, PhD3*, Sarah Ryley4*, Elspeth Payne, MD, PhD, FRCPath5*, Onima Chowdhury, MD, DPhil6, Jennifer Strefford7* and Thomas Coats, MBBS, PhD, FRCPath8*

1Oxford University Hospitals, Oxford, United Kingdom
2Bristol Genetics Laboratory, Bristol, GBR
3Health service laboratories, UCLH, London, GBR
4Churchill Hospital, Oxford, Oxord, United Kingdom
5University College London Hospitals NHS Foundation Trust, London, United Kingdom
6Oxford University Hospitals, Oxford, GBR
7Churchill Hospital, Oxford, Oxford, GBR
8Royal Devon & Exeter NHS Foundation Trust Wonford Site, Exeter, United Kingdom

*signifies non-member of ASH
  翻译: